Pharmacological inhibition of SIRT2 blocks TNF-α-induced cell necrosis, suggesting that SIRT2 inhibitors may constitute a novel approach to prevent necrotic injury, including ischemic stroke and myocardial infarction [166]. The gene discussed is SIRT2; the disease is ischemic stroke.